Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CADI-R301
- Development stage
- Preclinical
- Lead developer
- Bio-Modeling Systems
01
Overview
CADI-R301 is a discovery-stage therapeutic research program developed by Bio-Modeling Systems (BMSystems) targeting disorders of the Central Nervous System (CNS) and Peripheral Nervous System (PNS). The program is built upon the company's proprietary CADI™ (Computer-Assisted Deductive Integration) platform, a heuristic systems biology modeling technology designed to integrate heterogeneous biological data to reveal non-obvious pathological mechanisms. CADI-R301 aims to identify novel therapeutic targets and treatment protocols for complex neurological conditions. As it is currently in the discovery phase, specific molecular targets and the final therapeutic modality have not been publicly disclosed.
Beyond the preview
Go deeper on CADI-R301.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CADI-R301.